FDA Adverse Event
Injury
Summary report: N
SUPERA BILIARY STENT DELIVERY SYSTEM
MDR report key: 1930712
·
Received December 14, 2010
Report
- Report Number
- 3005325609-2010-00019
- Event Type
- Injury
- Date Received
- December 14, 2010
- Date of Event
- September 22, 2010
- Report Date
- November 15, 2010
- Manufacturer
- IDEV TECHNOLOGIES, INC.
- Product Code
- FGE
- PMA / PMN Number
- K071646
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
THE CAUSE OF THE EVENT IS UNK. NO INDICATION OF A DEVICE MALFUNCTION. THE CAUSE IS LIKELY THE PT'S DISEASE PROGRESSION.
Description of Event or Problem · 1
THE PT IS CURRENTLY ENROLLED IN THE (B)(6). AT 17 MONTHS POST IMPLANT THE PT WAS ADMITTED FOR INVASIVE DIAGNOSTIC TESTING OF SIGNIFICANT STENOSIS OF BOTH SUPERFICIAL FEMORAL ARTERIES AS PART OF A CONTINUED ANGIOLOGICAL TREATMENT FOR ARTERIAL OCCLUSIVE DISEASE, STAGE IIB. INTERVENTION INCLUDED PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) OF THE IN-STENT STENOSIS. FOLLOWING PTA, ANGIOGRAPHIC RESULTS WERE "VERY GOOD." THE CAUSE OF THE RESTENOSIS IS UNK; THERE IS NO INDICATION OF A DEVICE MALFUNCTION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | SUPERA BILIARY STENT DELIVERY SYSTEM | FGE | IDEV TECHNOLOGIES, INC. | SE-06-060-120-G2 | 302041 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 81 YR | Hospitalization| R |